These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7982944)
1. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins. Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944 [TBL] [Abstract][Full Text] [Related]
2. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Gabel BR; Koschinsky ML Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051 [TBL] [Abstract][Full Text] [Related]
3. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs. Schaefer JR; Scharnagl H; Baumstark MW; Schweer H; Zech LA; Seyberth H; Winkler K; Steinmetz A; März W Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):348-53. PubMed ID: 9081691 [TBL] [Abstract][Full Text] [Related]
13. The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100. Maher VM; Gallagher JJ; Myant NB Atherosclerosis; 1993 Aug; 102(1):51-61. PubMed ID: 8257452 [TBL] [Abstract][Full Text] [Related]
14. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. Koschinsky ML; Côté GP; Gabel B; van der Hoek YY J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100. Hansen PS; Meinertz H; Jensen HK; Fruergaard P; Launbjerg J; Klausen IC; Lemming L; Gerdes U; Gregersen N; Faergeman O Arterioscler Thromb; 1994 Feb; 14(2):207-13. PubMed ID: 8305410 [TBL] [Abstract][Full Text] [Related]
16. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979 [TBL] [Abstract][Full Text] [Related]
17. Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity? Maher VM; Gallagher JJ; Thompson GR; Myant NB Atherosclerosis; 1995 Nov; 118(1):105-10. PubMed ID: 8579620 [TBL] [Abstract][Full Text] [Related]
18. Familial defective apolipoprotein B-100 (FDB): effect of simvastatin therapy on LDL-receptor binding. Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR Atherosclerosis; 1996 Aug; 125(1):103-10. PubMed ID: 8831932 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred. Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645 [TBL] [Abstract][Full Text] [Related]